| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $3.41B | -4.5% |
| Cost of Revenue | $2.05B | -7.3% |
| Gross Profit | $1.36B | -0.0% |
| R&D Expense | $66.5M | +0.8% |
| SG&A Expense | $870.0M | -1.4% |
| Operating Income | $478.7M | +3.5% |
| Pre-tax Income | $328.0M | +15.0% |
| Income Tax | $107.5M | +279.9% |
| Net Income | $194.9M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $682.0M | -5.4% |
| Accounts Receivable | $722.7M | -5.9% |
| Inventory | $676.0M | +4.4% |
| Current Assets | $2.31B | -4.0% |
| Total Assets | $6.79B | -6.5% |
| Current Liabilities | $721.5M | -7.4% |
| Long-term Debt | $2.35B | -4.1% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $379.6M | -21.1% |
| Capital Expenditures | $83.1M | +35.8% |
| Investing Cash Flow | -$104.4M | -27.6% |
| Financing Cash Flow | -$286.7M | -11.0% |
| Free Cash Flow | $296.5M | -29.4% |
| -16.3% |
| EPS (Basic) | $0.75 | -12.8% |
| EPS (Diluted) | $0.74 | -11.9% |
| Total Liabilities |
| $3.45B |
| -7.1% |
| Stockholders' Equity | $3.02B | -6.1% |